ICU Medical, Inc.
ICUI
$125.85
-$2.93-2.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.15% | -8.85% | -7.98% | 6.71% | 7.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.15% | -8.85% | -7.98% | 6.71% | 7.14% |
| Cost of Revenue | -16.10% | -12.54% | -12.40% | 3.46% | -3.30% |
| Gross Profit | -10.68% | -1.94% | 0.31% | 13.42% | 32.45% |
| SG&A Expenses | -1.91% | -6.11% | -0.10% | -0.27% | 2.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.84% | -10.19% | -8.73% | 2.53% | -1.61% |
| Operating Income | -43.36% | 27.18% | 9.46% | 414.97% | 946.11% |
| Income Before Tax | -323.77% | 77.39% | 286.95% | 70.34% | 122.40% |
| Income Tax Expenses | -108.28% | -104.37% | -37.11% | 69.07% | 264.05% |
| Earnings from Continuing Operations | 33.97% | 89.70% | 265.08% | 60.79% | -38.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.97% | 89.70% | 265.08% | 60.79% | -38.96% |
| EBIT | -43.36% | 27.18% | 9.46% | 414.97% | 946.11% |
| EBITDA | -22.34% | 1.13% | -4.18% | 28.98% | 91.52% |
| EPS Basic | 34.49% | 89.81% | 263.41% | 61.30% | -36.97% |
| Normalized Basic EPS | -74.07% | 251.54% | 495.03% | 128.79% | 153.66% |
| EPS Diluted | 35.06% | 89.63% | 262.50% | 61.31% | -38.15% |
| Normalized Diluted EPS | -74.07% | 251.54% | 494.03% | 128.79% | 153.66% |
| Average Basic Shares Outstanding | 0.80% | 1.01% | 1.03% | 1.31% | 1.46% |
| Average Diluted Shares Outstanding | 0.80% | 1.01% | 1.29% | 1.31% | 1.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |